Daniel J. George, M.D.
Duke Cancer Center
Director of Genitourinary Oncology
Medical Oncologist
Dr. Daniel J. George, MD, is a distinguished Medical Oncologist at Duke University, specializing in the comprehensive care of patients with urologic cancers, with a primary focus on prostate, kidney, bladder, and testicular cancer. Dr. George prioritizes providing a profound understanding of each patient’s case and presenting viable options, instilling knowledge as a source of reassurance and empowerment.
Education & Training:
Fellowship
Medical Oncology, Johns Hopkins Hospital (Maryland), 1995-1998
Residency
Internal Medicine, Johns Hopkins Hospital (Maryland), 1992-1995
Education
MD, Duke University School of Medicine, 1992
Current Appointments and Affiliations:
Eleanor Easley Distinguished Professor in the School of Medicine, Medicine, Medical Oncology 2023
Professor of Medicine, Medicine, Medical Oncology 2015
Professor in Surgery, Surgery 2015
Member of the Duke Cancer Institute, Duke Cancer Institute 2003
Professional Accomplishments:
As the leader of a robust clinical research team at Duke, Dr. George has significantly contributed to advancing therapeutic approaches and enhancing care outcomes for patients with urologic cancers. His research portfolio spans interventional trials involving novel therapies, diagnostic tests, and markers delving into cancer biology, response, and overall outcomes. Driven by a keen interest in immuno-oncology agents and targeted therapies, his work embodies a commitment to pioneering advancements in cancer treatment.
Leadership and Impact:
Dr. George’s research extends beyond conventional boundaries, exploring lifestyle interventions and support mechanisms to improve the overall cancer experience for patients. His team’s dedication is evident in the inclusion of diverse professionals fostering a multidisciplinary approach to cancer care. With a notable proportion of African American patients under his care, Dr. George places a particular emphasis on understanding the unique aspects of their diseases and strives to enhance care delivery for this population.
Dr. George distinguishes himself through his personal approach, fostering trust with patients through genuine care and unwavering expertise. His relentless pursuit of knowledge and innovation underscores his commitment to transforming the landscape of urologic cancer care, making him an invaluable asset to both Duke University and the broader medical community.
Meet the Duke Team
Michael R. Harrison, M.D.
Medical Oncologist
Educational Credentials:
- M.D., University of Wisconsin School of Medicine and Public Health
- Residency in Internal Medicine, University of Wisconsin Hospital and Clinics
- Fellowship in Medical Oncology, University of Wisconsin Carbone Cancer Center
Career Highlights and Research Interests:
- Specializes in genitourinary cancers, including bladder, prostate, testicular, and kidney cancers.
- Focuses on educating patients about their disease and treatment options to facilitate shared decision-making.
- Actively involved in clinical trials exploring novel therapies for genitourinary malignancies.
- Published research on immunotherapy and targeted treatments in advanced bladder cancer.
- Committed to advancing personalized medicine approaches to improve patient outcomes.
Dr. Harrison’s dedication to patient education and innovative research significantly contributes to the mission of the Kidney Cancer Research Consortium.

Naomi Haas
UPenn

Hans Hammers
UT Southwestern

Eric Jonasch
MD Anderson

David McDermott

Brian Rini
Vanderbilt University



